Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Cell Reports|October 17, 2019
The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq ApproachHiroo Katsuya, Saiful Islam, Benjy Jek Yang Tan, et al.
Cancer Science|July 22, 2024
Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305)Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, et al.
Cancer Science|February 12, 2021
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyNobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, et al.
Microbiology Spectrum|November 15, 2023
Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situationsMadoka Kuramitsu, Haruka Momose, Yuichiro Uchida, et al.
Microbiology and Immunology|August 21, 2018
Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in JapanMadoka Kuramitsu, Kazu Okuma, Makoto Nakashima, et al.
The Lancet. Oncology|November 1, 2024
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 studyDai Maruyama, Eric Jacobsen, Pierluigi Porcu, et al.
Cancer Science|August 9, 2020
R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 studyYoshitoyo Kagami, Kazuhito Yamamoto, Taro Shibata, et al.
Blood Advances|February 16, 2021
A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trialKen Ohmachi, Tomohiro Kinoshita, Kensei Tobinai, et al.
Journal of Clinical Microbiology|July 14, 2017
Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis ResultsMadoka Kuramitsu, Tsuyoshi Sekizuka, Tadanori Yamochi, et al.
Japanese Journal of Clinical Oncology|September 2, 2025
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphomaKen Ohmachi, Tomohiro Kinoshita, Dai Maruyama, et al.
Pageof 10